Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2011-05-24
2011-05-24
Romeo, David S (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C536S023500, C536S023400, C435S069100, C435S069700, C424S130100, C424S139100, C424S143100, C424S185100, C514S001100, C514S019300, C514S021200
Reexamination Certificate
active
07947805
ABSTRACT:
The present invention relates to BCMA polypeptide variants and their uses, particularly for therapeutic or prophylactic treatment in human subjects. The invention also relates to nucleic acids encoding said polypeptides, vectors comprising such nucleic acids and recombinant cells containing the same. The invention further discloses methods of producing such polypeptides, as well as methods and tools for detecting or dosing these polypeptides in any sample.
REFERENCES:
patent: 7083785 (2006-08-01), Browning et al.
patent: 7276241 (2007-10-01), Schneider et al.
patent: 2006/0286093 (2006-12-01), Gross et al.
patent: WO 00/68378 (2000-11-01), None
patent: WO 01/12812 (2001-02-01), None
patent: WO 01/24811 (2001-04-01), None
patent: WO 01/87977 (2001-11-01), None
patent: WO 03/072713 (2003-09-01), None
Smirmova et al., Mol Immunol. Feb. 2008;45(4):1179-1183.
Database EMBL ‘Online’, Database Accession No. BG183381, “RST2275 Athersys RAGE Library Homo sapiens cDNA, mRNA sequence”, Apr. 26, 2001, vol. 19, No. 5, XP002323758, pp. 1-2.
Gross, J. et al. “TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease”,Nature, Apr. 27, 2000, pp. 995-999, vol. 404.
Hatzoglou, A. et al. “TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-KB, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase”,Journal of Immunology, Aug. 1, 2000, pp. 1322-1330, vol. 165, No. 3.
Khare, S. et al. “Severe B cell Hyperplasia and autoimmune disease in TALL-1 transgenic mice”,Proc. Natl. Acad. Sci. USA, Mar. 28, 2000, pp. 3370-3375, vol. 97, No. 7.
Kim, H. et al. “Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation”,Nature Structural Biology, May 2003, pp. 342-348, vol. 10, No. 5.
Laabi, Y. et al. “A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma”,The EMBO Journal, Nov. 1992, pp. 3897-3904, vol. 11, No. 11.
Laabi, Y. et al. “The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed”,Nucleic Acids Research, 1994, pp. 1147-1154, vol. 22, No. 7.
Liu, Y. et a/. “Ligand-receptor binding revealed by the TNF family member TALL-1”,Nature, May 1, 2003, pp. 49-56, vol. 423.
Mackay, F. etal. “The TNF family members BAFF and APRIL: the growing complexity”,Cytokine&Growth Factor Reviews, 2003, pp. 311-324, vol. 14, Nos. 3-4.
Mackay, F. et al. “Mice Transgenic for BAFF Develop Lymphocytic Disorders Along with Autoimmune Manifestations”,J. Exp. Med., Dec. 6, 1999, pp. 1697-1710, vol. 190, No. 11.
Mackay, F. et al. “BAFF and APRIL: A Tutorial on B Cell Survival”,Annu. Rev. Immunol., 2003, pp. 231-264, vol. 21.
Madry, C. et al. “The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily”,International Immunology, Nov. 1998, pp. 1693-1702, vol. 10, No. 11.
Marsters, S. et al. “Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI”,Current Biology, Jun. 29, 2000, pp. 785-788, vol. 10, No. 13.
O'Connor, B. et al. “BCMA Is Essential for the Survival of Long-lived Bone Marrow Plasma Cells”,J. Exp. Med., Jan. 5, 2004, pp. 91-97 vol. 199, No. 1.
Patel, D. etal. “Engineering an APRIL-specific B Cell Maturation Antigen”,The Journal of Biological Chemistry, Apr. 16, 2004, pp. 16727-16735, vol. 279, No. 16.
Pelletier, M. et al. “Comparison of Soluble Decoy IgG Fusion Proteins of BAFF-R and BCMA as Antagonists for BAFF”,The Journal of Biological Chemistry, Aug. 29, 2003, pp. 33127-33133, vol. 278, No. 35.
Rennert. P. et al. “A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member APRIL, Inhibits Tumor Cell Growth”,J. Exp. Med., Dec. 4, 2000, pp. 1677-1683, vol. 192, No. 11.
Shu, H.-B. et al. “B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1”,Proc. Natl. Acad. Sci. USA, Aug. 1, 2000, pp. 9156-9161, vol. 97, No. 16.
Wallweber, H. et al. “The Crystal Structure of a Proliferation-inducing Ligand, APRIL”,J. Mol. Biol., Oct. 15, 2004, pp. 283-290, vol. 343.
Xu, S. et a/. “B-Cell Maturation Protein, Which Binds the Tumor Necrosis Factor Family Members BAFF and APRIL, Is Dispensable for Humoral Immune Responses”,Molecular and Cellular Biology, Jun. 2001, pp. 4067-4074, vol. 21, No. 12.
Yu, G. et al. “APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity”,Nature Immunology, Sep. 2000, pp. 252-256, vol. 1, No. 3.
Belloir Benedicte
Cledat Anne-Francoise
Primas Gwenael
Gamett Daniel C
Merck Serono S.A.
Romeo David S
Saliwanchik Lloyd & Eisenschenk
LandOfFree
BCMA polypeptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BCMA polypeptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BCMA polypeptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643544